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 Abstract - Study objectives:  Oral appliances 
have gained their place in the treatment of 
obstructive sleep apnea (OSA) where custom-made 
titratable mandibular advancement devices (MAD) 
have become the oral appliance of choice. This study 
aimed to asses the value of the drug-induced sleep 
endoscopy (DISE) using a MAD in the prediction of 
treatment outcome for OSAHS 
Methods: This is a prospective, single-center 
cohort study that enrolled sixty-six consecutive 
patients with diagnosed OSA (5 events/h < apnea-
hypopnea index (AHI) < 50 events/h) to be treated 
with a custom-made titratable MAD. The patients 
were evaluated polysomnographically with the MAD 
in situ after the adaptation and titration period of 3 
months. The associations between findings during 
DISE and treatment outcome were assessed 
Results: The subjects showed a wide range of 
severity of OSAHS pre-treatment: median AHI was 
43.10 with a range from 20.13 to 66.07. The 
simulation bite was associated with a significant 
increase in cross-sectional area at level of the 
velopharynx, tongue base and epiglottis. MAD 
treatment response in the studied population was 
91%, with a mean AHI improving from 43.10 to 
12.93. 
Conclusions: Drug-induced sleep endoscopy 
with simulation bite is an acceptably reproducible 
technique for determining the sites of obstruction in 
OSAHS subjects; it thus offers possibilities as a 
prognostic indicator for treatment with MAD 
 
 
Keywords: oral appliance, drug-induced sleep endoscopy, 
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I.  INTRODUCTION 
 
 Obstructive sleep apnea/hypopnea syndrome 
(OSAHS) is characterized by recurrent episodes of apnea 
and hypopnea during sleep, due to repetitive upper airway 
(UA) collapse, often resulting in decreased oxygen blood 
levels and arousal from sleep [1,2]. Continuous positive 
airway pressure (cPAP) therapy is considered the gold 
standard for treatment, but oral appliance therapy could 
represent the main alternative treatment modality.  
Mandibular advancement devices (MADs) are the most 
common class of oral appliances to treat OSAHS [3-5]; in 
selecting patients who might benefit from MAD 
treatment, several predictor factors of treatment outcome 
have been described in the literature, such as lower apnea–
hypopnea index (AHI), lower body mass index (BMI), 
lower age, female gender and supine-dependent OSAHS 
[6,7]. Firstly described in 1991 by Croft and Pringle, sleep 
nasendoscopy or drug-induced sleep endoscopy (DISE) 
can be used to identify the level of snoring and UA 
collapse; a “chin-lift” manoeuvre (mandible actively 
guided forward by “grasping” it and advancing it to a 
maximal protruded position) can be added to the DISE 
procedure [8]. Some authors considered DISE a good 
technique for researchers to assess the site and the pattern 
of collapse, but they suggest that it should be correlated to 
clinically available measures, such awake nasendoscope 
to validate this. 
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The aim of this paper is to assess the value of the DISE 
using a MAD in the prediction of treatment outcome for 
OSAHS. 
 
II.  METHODOLOGY 
 
 Sixty-six consecutive patients admitted to our 
Department with diagnosis of OSAHS were enrolled in 
the study. Sleeping Breath Disorders diagnosis was based 
on polysomnography (PSG)(ApneaLink Air. ResMed, 
Germany.). Parameters assessed were: AHI (Apnea 
Hypopnea Index) corresponding to average of apneas and 
hypopneas per hour of sleep; ODI (Oxygen Desaturation 
Index) which was expression of the number of 
desaturation events (> 3%) per hour of sleep; NADIR (the 
lower O2 saturation level). 
OSAHS is defined by an AHI > 5h/sleep; baseline 
characteristics are shown in Table I. 
Inclusion criteria were: >18 years of age, a confirmed 
diagnosis of OSAHS (AHI > 5h/sleep), prepared to wear a 
MAD, sufficient healthy teeth to allow MAD 
construction. We excluded patients with history of poorly 
controlled epilepsy, history of allergy to metals, 
edentulous or with insufficient teeth. 
The study was approved by the Ethics Committee. All 






DISE with simulation bite 
The technique of sleep nasendoscopy (SNE) was 
developed by Croft and Pringle in 1991: subjects are 
pharmacologically induced into a light phase of sleep, and 
the UA are directly visualized using a flexible fiber-optic 
endoscope. Levels of partial or complete obstruction are 
noted and the following grading scheme is applied: grade 
1: palatal level snoring, grade 2: palatal level obstruction, 
grade 3: multi-segmental involvement – intermittent oro- 
and hypopharyngeal collapse, grade 4: sustained multi-
level collapse, grade 5: tongue base obstruction [9]. An 
improvement of the nasendoscopic procedure has been to 
gently advance the mandible during sedation to mimic the 
effect of MAD and to examine the effect of this 
manoeuvre on UA patency and snoring: if airway 
dimensions improve and snoring is reduced, MAD may be 
indicated, regardless of the exact grading. 
Artificial sleep was induced by intravenous administration 
propofol through a target-controlled infusion system in the 
operating room, with the patients in the supine position, 
with peripheral venous punction, monitoring oxygen 
saturation, cardiac rhythm and Bispectral Index (BIS).  
BIS monitoring provides direct information about the 
effects of anesthetics and sedatives on the brain by placing 
a sensor on a patient's forehead [10,11]. The BIS monitor 
translates the information from electrical brain activity 
into a single number from 100 (indicating an awake 
patient) to 0 (indicating the absence of brain electrical 
activity).  The search value during DISE ranged from 50 
to 70. 
When adequate sedation had been achieved, a 
nasolaryngoscope (Olympus ENF-GP, diameter 3.7 mm; 
Olympus Europe GmbH, Hamburg, Germany) was passed 
without local anaesthetic through the more patent nostril 
identifying the level(s) of any obstruction. Video-editing 
software was used to capture frames from the digital video 
recording of the nasolaryngoscopy. 
All endoscopic findings have been classified according to 
the VOTE classification [12,13] which considers the 
following sites of obstruction: Velum, Oropharynx, 
Tongue base, Epiglottis. For each structure the minimal 
sectional area has been classified in 3 obstructing grades:  
• grade 0: no obstruction; 
• grade 1: partial obstruction; 
• grade 2: complete obstruction. 
Identification of the obstructing configuration was 
evaluated according to the shape of the dynamic collapse 
(antero-posterior, lateral or concentric when combination 
of the former two).  
The DISE was preceded by the registration of a simulation 
bite for each patient. A customized, removable, Herbst 
appliance was created for each subject with the mandible 
in a position of maximum, comfortable protrusion. The 
patients were educated to protrude the mandible forward 
toward the maximal comfortable protrusion (MCP). We 
repeated three times and recorded this position. 
Baseline DISE was complemented with the use of intra-
orally simulation bite, placed by a dentist and preceded by 
intravenous administration of sedative drugs, in order to 
avoid jaw clamping or waking up the patient.  
In the first phase of DISE we assessed the UA dimensions 
with the intra-orally simulation bite. The simulation bite 
was then removed, allowing assessment of the UA 
without any mandibular repositioning.  
 
Mandibular advanced device (MAD) 
A custom-made mandibular advancement device (MAD) 
was fit for each patient; this consists of two dental clips 
(attached to each other) with an adjunct for adjust the 
manipular protrusion in the frontal teeth area. The patient 
needed three months to acclimatize with MAD; during 
this period, the adjunct was assessed to obtain a maximal 
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comfortable protruded mandibular position or a resolute 
of the apneas. 
 
Evaluation 
The patients were evaluated by an ambulatory 
polysonnography with the MAD in situ after the three-
months adaptation and titration period. The associations 
between findings during DISE and treatment outcome 
were assessed. We considered as a treatment response a 
50% reduction in AHI  and an AHI value >20 [14]. 
 
III.  RESULTS 
 
The subjects showed a wide range of severity of OSAHS 
pre-treatment: median AHI was 43.10 with a range from 
20.13 to 66.07 (Table II).  
 
 
Of sixty-six patients, the most suffered form severe 
OSAHS (45.4%), while seventeen patients (25.8%) and 
nineteen patients (28.8%) suffered from moderate and 





The DISE without simulation bite showed most frequently 
antero-posterior collapse at the level of the tongue base, a 
lateral collapse of the oropharynx lateral walls and a 
concentric collapse at the level of the palate.  We found 
combined collapses in 65% of patients.  
The simulation bite was associated with a significant 
increase in cross-sectional area at level of the 
velopharynx, tongue base and epiglottis. MAD treatment 
response in the studied population was 91%, with a mean 












The presence of palatal (concentric or antero-posterior) 
and tongue base antero-posterior collapse at baseline 
evaluation was associated with greater response to 
treatment, while the presence of oropharynx-lateral walls 
collapse at baseline evaluation showed a tendency towards 






IV.  DISCUSSION 
 
 OSAHS is defined as a disorder characterized by 
repeated collapse of the UA during sleep, with periodic 
apnea of breathing [15]. Depending on the severity of the 
condition, patients can be managed by nasally applied 
continuous positive airways pressure (nCPAP), 
mandibular advancement device (MAD) therapy or a 
range of surgical techniques [16,17]. 
Although less efficacious than CPAP, MADs are a 
simpler and often a more acceptable treatment modality, 
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and it can represent a rescue therapy in patients with mild 
to severe OSA who are reluctant or non-responding to 
CPAP, or fail to use CPAP [18]. There has been 
increasing evidences about the use of MADs for the 
therapy of OSAHS and this treatment modality has been 
shown be more beneficial on polysomnographic indices of 
OSAHS, subjective and objective measures of sleepiness, 
blood pressure, neuropsychological functioning and 
quality of life.  
Overall, ~60–70% of patients achieve a reduction of 
≥50% in AHI, with a reduction of AHI to <5 events h
-1
 in 
35–40% of patients [19-21].  
MADs are worn intra-orally during the night and 
mechanically protrude the mandible, commonly with a 
design to gradually protrude the mandible applying a 
mechanical advancing mechanism, to prevent UA collapse 
and increase the cross-sectional airway dimensions, and 
thereby reduce snoring and obstructive sleep apneas [22]. 
Soft tissue structures within the palatoglossal and 
palatopharyngeal arches connect the mandible, tongue, 
lateral pharyngeal walls and soft palate; it has been 
proposed that such soft tissue connections may be 
stretched by mandibular advancement [23,24].  
Using cephalometry, Tsuiki et al. [25] concluded that an 
anteriorly titrated mandibular position reduced obstructive 
sleep apnea severity, enlarged the velopharynx and 
decreased the curvature of the anterior velopharyngeal 
wall in good responders [5]. As the tongue is brought 
forwards, the soft palate will tend to follow to maintain a 
posterior oral seal, providing variable improvement in 
individuals with multi-level involvement [26]. This would 
explain the findings of Henke et al [27] that the MAD 
could be effective where the sites of obstruction include 
the velopharynx, and supports the more varied response 
observed here in subjects with multi-level involvement. 
Several methods have been proposed to evaluate the effect 
of MAD on UA patency to predict its efficacy in the 
treatment of OSAHS. Although helpful in selected 
subjects, neither CT nor MRI can be justified routinely on 
the basis of expense, limited access and, in the case of CT, 
relatively high doses of radiation.  
Anneclaire et al. [3] evaluated the associations between 
the findings during sleep nasendoscopy with simulation 
bite and treatment outcome. They reported a higher 
percentage of collapse at the level of the palate, followed 
by the tongue base and the epiglottis, while the 
oropharynx level was reported less commonly. There were 
several combinations of collapse levels, and the most 
frequent pattern was the combination of palatal and 
tongue base collapse (34.4%), while multi-level collapse 
in general was noted in 87.2% of all patients. In the 
present study, we reported a higher percentage of antero-
posterior collapse at the level of the tongue base, a lateral 
collapse of the oropharynx lateral walls and a concentric 
collapse at the level of the palate. 
When UA collapse was completely resolved using the 
simulation bite, the patient was considered a “well 
suitable” candidate for MAD treatment; patients with a 
partial resolution (residual collapse at one or more UA 
levels) were considered as “partially suitable”; patients 
were considered “not suitable” when UA collapsibility 
increased or remained unchanged with the simulation bite 
in situ.  
They defined treatment response as a reduction in AHI 
following MAD treatment of ≥50% compared to baseline; 
overall MAD treatment response in the studied population 
was 68,9%, with a mean AHI improving from 21.4 to 8.9 
h
1
 sleep. The presence of palatal collapse at baseline 
evaluation was associated with treatment response, while 
presence of hypopharyngeal collapse at baseline 
evaluation showed a tendency towards an association with 
a less favourable treatment outcome. The results of this 
study demonstrated a statistically significant association 
between a positive effect of the simulation bite on the UA 
patency during sleep nasendoscopy and treatment 
response with MAD (P < 0.01). We observed a positive 
response to treatment with MAD in 86.7% of antero-
posterior velum collapse, 80% of concentric velum 
collapse, and 93.3% of antero-posterior tongue base 
collapse. 
Ama et al. [28] evaluated the role of SNE in conjunction 
with mandibular protrusion to predict the success of MAD 
therapy in the treatment of patients with OSAHS; Chan et 
al [19] evaluated the role of MAD on UA anatomy using 
nasopharyngoscopy performed during wakefulness in 
patients with OSAHS and the potential role of this 
approach for identifying responder and nonresponder 
subjects, finding that the increase in the velopharyngeal 
cross-sectional area caused by mandibular advancement 
was significantly associated with a treatment response on 
polysomnography, while an increase in the cross-sectional 
area of the oropharynx or hypopharynx was not 
significantly associated with treatment outcome. 
The results of our study suggest that the mandibular 
advancement manoeuvre during DISE could help to 
optimise the selection of patients for oral device 
treatment. 
The major flaw of this study is that the assessment of the 
UA during sleep nasendoscopy is based on subjective 
findings. 
 
V.  CONCLUSION 
 
 The development of a simple and clinically 
useful tool to predict which patients will respond to MAD 
therapy would aid the appropriate selection of patients. 
Drug-induced sleep endoscopy with simulation bite is a 
reproducible technique to assess the sites of obstruction in 
OSAHS patients, and it can be used as a prognostic 
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